[go: up one dir, main page]

PT969846E - Composicoes e metodos para reduzir a hipertensao ocular - Google Patents

Composicoes e metodos para reduzir a hipertensao ocular

Info

Publication number
PT969846E
PT969846E PT98916948T PT98916948T PT969846E PT 969846 E PT969846 E PT 969846E PT 98916948 T PT98916948 T PT 98916948T PT 98916948 T PT98916948 T PT 98916948T PT 969846 E PT969846 E PT 969846E
Authority
PT
Portugal
Prior art keywords
compositions
methods
reducing eye
eye hypertension
hypertension
Prior art date
Application number
PT98916948T
Other languages
English (en)
Inventor
Kenneth Warren Reed
Shau-Fong Yen
Regina Flinn Peacock
Mary Sou
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38729083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT969846(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT969846E publication Critical patent/PT969846E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT98916948T 1997-03-17 1998-03-13 Composicoes e metodos para reduzir a hipertensao ocular PT969846E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81922197A 1997-03-17 1997-03-17

Publications (1)

Publication Number Publication Date
PT969846E true PT969846E (pt) 2004-05-31

Family

ID=38729083

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98916948T PT969846E (pt) 1997-03-17 1998-03-13 Composicoes e metodos para reduzir a hipertensao ocular

Country Status (32)

Country Link
EP (1) EP0969846B2 (pt)
JP (2) JP4920124B2 (pt)
KR (1) KR100555818B1 (pt)
CN (1) CN1236775C (pt)
AR (2) AR002194A1 (pt)
AT (1) ATE257385T1 (pt)
AU (1) AU738781B2 (pt)
BR (2) BR9808016A (pt)
CA (1) CA2280089C (pt)
CL (1) CL2009001870A1 (pt)
CO (1) CO4940427A1 (pt)
CY (1) CY2526B1 (pt)
CZ (1) CZ299833B6 (pt)
DE (1) DE69820997T3 (pt)
DK (1) DK0969846T4 (pt)
EE (1) EE04091B1 (pt)
ES (1) ES2214706T5 (pt)
HU (1) HU228896B1 (pt)
ID (1) ID22389A (pt)
IL (1) IL131041A0 (pt)
MY (1) MY122237A (pt)
NO (1) NO327713B1 (pt)
NZ (1) NZ337322A (pt)
PE (1) PE61899A1 (pt)
PL (1) PL197509B1 (pt)
PT (1) PT969846E (pt)
RU (1) RU2197970C2 (pt)
SI (1) SI0969846T2 (pt)
TW (1) TW527187B (pt)
UA (1) UA63938C2 (pt)
WO (1) WO1998041208A1 (pt)
ZA (1) ZA982188B (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
AR002194A1 (es) * 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
US6187818B1 (en) 1998-06-17 2001-02-13 Pharmacia & Upjohn Company Prostaglandins formulation and process
JP4880808B2 (ja) * 1999-11-15 2012-02-22 久光製薬株式会社 人工涙液型点眼剤組成物
JP4000505B2 (ja) 1999-12-01 2007-10-31 第一三共株式会社 緑内障を治療するための併用剤
CN1243548C (zh) * 2000-09-13 2006-03-01 参天制药株式会社 滴眼液
AU2002218527A1 (en) * 2000-12-05 2002-06-18 Sankyo Company Limited Ocular tension-lowering compositions for topical administration
US20020198209A1 (en) * 2001-05-03 2002-12-26 Allergan Sales Inc. Compositions having enhanced pharmacokinetic characteristics
US7074827B2 (en) 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma
RU2266572C1 (ru) * 2004-03-17 2005-12-20 Российский государственный медицинский университет Способ моделирования злокачественной артериальной гипертонии
US20070208068A1 (en) * 2004-03-18 2007-09-06 R-Tech Ueno, Ltd. & Astellas Pharma Inc. Aqueous Composition Comprising Thiazole Derivative
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
GB0501192D0 (en) * 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
US7851504B2 (en) * 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
DE202005005094U1 (de) * 2005-03-31 2005-07-28 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Ophthalmische Zusammensetzung
ES2460967T3 (es) * 2005-08-02 2014-05-16 Santen Pharmaceutical Co., Ltd. Método para la prevención de la degradación de una sustancia térmicamente inestable
JP5252787B2 (ja) * 2005-08-02 2013-07-31 参天製薬株式会社 熱的に不安定な薬物の分解抑制方法
JP2007099647A (ja) * 2005-09-30 2007-04-19 Kobayashi Pharmaceut Co Ltd 粘膜適用組成物
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
AU2007225798B2 (en) * 2006-03-13 2012-09-06 R-Tech Ueno, Ltd. Aqueous composition
EP2010143B1 (en) * 2006-03-17 2015-08-12 Johnson & Johnson Vision Care, Inc. Stabilized ophthalmic compositions comprising oxidatively unstable components
AU2007313684A1 (en) * 2006-10-31 2008-05-08 Alcon Research, Ltd. PAI-1 binding modulators for the treatment of ocular disorders
EP2123278B1 (en) * 2007-02-07 2013-01-09 Teika Pharmaceutical Co., Ltd. Eye drop preparation comprising latanoprost
JP2009073788A (ja) * 2007-09-21 2009-04-09 Teika Seiyaku Kk イソプロピルウノプロストン含有眼用組成物
EA019867B1 (ru) * 2007-10-08 2014-06-30 Фовея Фармасьютикалс Водные офтальмологические препараты
TWI544927B (zh) * 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
DK2420223T3 (da) * 2008-03-17 2017-11-06 Novartis Ag Vandige farmaceutiske sammensætninger med borat-polyol-komplekser
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
RU2402316C2 (ru) * 2009-01-11 2010-10-27 Пшеничников Виталий Георгиевич Фармацевтическая антиглаукомная композиция
US8952051B2 (en) * 2009-11-05 2015-02-10 Allergan, Inc. Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
CA2830896A1 (en) * 2011-04-12 2012-10-18 Yukihiko Mashima Aqueous ophthalmic composition
US20130029919A1 (en) 2011-07-26 2013-01-31 Allergan, Inc. Two part formulation system for opthalmic delivery
EP2567689A1 (en) 2011-09-12 2013-03-13 Visiotact Pharma Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
CA2858574C (en) 2011-12-07 2017-05-30 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
RU2697844C9 (ru) 2014-11-25 2019-10-01 Аллерган, Инк. Стабилизированные композиции для офтальмологического применения, содержащие омега-3-кислоты
US11752175B2 (en) * 2018-09-21 2023-09-12 Cornell University Compositions and methods for glaucoma
WO2020210784A1 (en) 2019-04-12 2020-10-15 Ecolab Usa Inc. Antimicrobial multi-purpose cleaner and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE91419T1 (de) * 1990-05-22 1993-07-15 R Tech Ueno Ltd Synergistische kombination zur ophthalmischen verwendung.
WO1992013836A1 (en) * 1991-02-07 1992-08-20 Allergan, Inc. 2-decarboxyl-2-hydroxyalkyl-5-trans prostaglandin f derivatives
US5767154A (en) * 1991-02-07 1998-06-16 Allergan 5-trans-prostaglandins of the F series and their use as ocular hypotensives
EP0708646A1 (en) * 1994-05-06 1996-05-01 Alcon Laboratories, Inc. Use of vitamin e tocopheryl derivatives in ophthalmic compositions
US5631287A (en) † 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
AR002194A1 (es) * 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.

Also Published As

Publication number Publication date
HUP0002194A3 (en) 2012-08-28
HUP0002194A2 (hu) 2000-12-28
JP2001515502A (ja) 2001-09-18
SI0969846T2 (sl) 2010-12-31
ZA982188B (en) 1998-09-17
PL335168A1 (en) 2000-04-10
CN1249687A (zh) 2000-04-05
DE69820997T2 (de) 2004-12-09
CZ299833B6 (cs) 2008-12-10
UA63938C2 (uk) 2004-02-16
AU738781B2 (en) 2001-09-27
AR011192A1 (es) 2000-08-02
RU2197970C2 (ru) 2003-02-10
HK1026841A1 (en) 2000-12-29
IL131041A0 (en) 2001-01-28
BR9808016A (pt) 2000-03-08
CZ325799A3 (cs) 2000-01-12
EP0969846B2 (en) 2010-08-25
JP2010043110A (ja) 2010-02-25
KR100555818B1 (ko) 2006-03-03
SI0969846T1 (en) 2004-06-30
CA2280089A1 (en) 1998-09-24
JP4920124B2 (ja) 2012-04-18
NO327713B1 (no) 2009-09-14
PE61899A1 (es) 1999-06-30
KR20000076330A (ko) 2000-12-26
TW527187B (en) 2003-04-11
EE9900410A (et) 2000-04-17
EP0969846A1 (en) 2000-01-12
CL2009001870A1 (es) 2010-01-22
DE69820997D1 (de) 2004-02-12
CY2526B1 (en) 2006-02-08
MY122237A (en) 2006-04-29
DE69820997T3 (de) 2011-10-06
CO4940427A1 (es) 2000-07-24
WO1998041208A1 (en) 1998-09-24
EP0969846B1 (en) 2004-01-07
ES2214706T3 (es) 2004-09-16
HU228896B1 (en) 2013-06-28
NZ337322A (en) 2001-05-25
DK0969846T4 (da) 2010-12-20
BRPI9816218B1 (pt) 2016-04-12
AU7035398A (en) 1998-10-12
ID22389A (id) 1999-10-07
NO994481L (no) 1999-09-16
NO994481D0 (no) 1999-09-16
CA2280089C (en) 2009-03-03
PL197509B1 (pl) 2008-04-30
ES2214706T5 (es) 2011-02-02
CN1236775C (zh) 2006-01-18
ATE257385T1 (de) 2004-01-15
AR002194A1 (es) 1998-01-07
DK0969846T3 (da) 2004-04-13
EE04091B1 (et) 2003-08-15

Similar Documents

Publication Publication Date Title
PT969846E (pt) Composicoes e metodos para reduzir a hipertensao ocular
FR2744908B1 (fr) Implant intraoculaire myopique
DE69501249D1 (de) Laser-Augenschutz
NO20010694D0 (no) Cornealt pålegg
EP1031063A4 (en) Shaped ophthalmic lenses
FR2784287B1 (fr) Segment d'expansion sclerale
DE69919808D1 (de) Augenschutz
FR2723691B1 (fr) Implant intra-oculaire
DE69736521D1 (de) Augentropfen
FI945014A7 (fi) Biohajoava silmän kovakalvon tappi
DE69811277D1 (de) Aminierungsverfahren
DE69828120D1 (de) Mikrokeratom für die augenchirurgie
AU2386895A (en) Substituted thiazole sulfonamides as antiglaucoma agents
NO20003786D0 (no) Oftalmisk sammensetning
DE69738054D1 (de) Intraokularlinse
DE69927428D1 (de) Intraocularlinse
DK1054662T3 (da) Vandoplöselige öjendråber
DE69806935D1 (de) Zweiteiliger schiffspoller
DE69828012D1 (de) Intraokularlinse
AU5342498A (en) Difluprednate-containing ophthalmic o/w emulsion composition
DE69802541D1 (de) Künstliche tränenformulierung
BR1100398A (pt) Composição oftalmológica
GB9719842D0 (en) Ophthalmic compositions for treating ocular hypertension
NO976133D0 (no) Oval oljelense
FR2761877B1 (fr) Prothese corneenne "post-mortem"